Promethazine and Tasigna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Tasigna (nilotinib hydrochloride monohydrate). Common drug interactions include abdominal tenderness among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Promethazine and Tasigna. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.



On Jul, 12, 2026

39 people who take Promethazine and Tasigna together, and have interactions are studied.

Promethazine and Tasigna drug interactions.

What are the common drug interactions of Promethazine and Tasigna, by gender? *:

female:

  1. Abdominal tenderness
  2. Abnormal loss of weight
  3. Anxiety
  4. Aspartate aminotransferase increased
  5. Blood albumin decreased
  6. Blood albumin increased
  7. Blood alkaline phosphatase increased
  8. Blood creatinine decreased
  9. Blood iron decreased
  10. Dizziness

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood pressure increased
  4. Heart rate increased
  5. Hypersensitivity
  6. Hypertension (high blood pressure)
  7. Infusion site erythema (reddening of the skin at infusion site)
  8. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  9. Infusion site pruritus (severe itching at infusion site)
  10. Infusion site swelling

What are the common drug interactions of Promethazine and Tasigna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diarrhoea
  2. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  3. Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Neoplasm malignant (cancer tumour)
  6. Oesophageal adenocarcinoma (a cancer tumour of an epithelium in oesophagus)
  7. Pain
  8. Second primary malignancy (after getting cure a cancer, a new cancer development)
  9. Thyroid neoplasm (tumour of thyroid)
  10. Ventricular extrasystoles (premature cardiac contraction)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Headache (pain in head)
  3. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  4. Menstrual disorder (disease of menstrual cycle)
  5. Oedema (fluid collection in tissue)
  6. Abdominal distension
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Asthma
  10. Bone pain

50-59:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Blood cholesterol increased
  3. Blood potassium decreased
  4. Breakthrough pain
  5. Chest pain
  6. Constipation
  7. Intervertebral disc degeneration (spinal disc degeneration)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Neck pain
  10. Pain

60+:

  1. Pruritus (severe itching of the skin)
  2. Dizziness
  3. Haemorrhage (bleeding)
  4. Headache (pain in head)
  5. Herpes zoster
  6. Hypertriglyceridaemia (excess of triglycerides in the blood)
  7. Hypopnoea (decrease in the breathing rate)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Rhinorrhoea (watery mucus discharge from the nose)

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 25 people, 64.10%
  2. Leukaemia (blood or bone marrow cancer): 3 people, 7.69%
  3. Pain: 2 people, 5.13%
  4. Gastrointestinal Stromal Tumor: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and Tasigna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promethazine and Tasigna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tasigna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tasigna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and nilotinib hydrochloride monohydrate (the active ingredients of Promethazine and Tasigna, respectively), and Promethazine and Tasigna (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: